glp 1 lasker 2024 Lasker-DeBakey Clinical Medical Research Award winner Svetlana Mojsov describes her discovery of glucagon-like peptide (GLP)-1, the biologically active incretin that led to development of effective GLP-1 analogues for diabetes and obesity GLP-1 Oral Solution – Affordable

These findings indicate that the relationship between metabolites in cord plasma and gene expression in cord plasma-exposed hepatocytes are distinct in pregnancies with and without obesity, and that the abundance of lipids and gene changes that may promote hepatic inflammation, activate Notch signaling, and impair mitochondrial function are among the top drivers of this relationship

Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) was not universally measured

Melanotan 2 has never been approved by the FDA, EMA, or any major regulator for any indication

Available evidence suggests that these agents have similar efficacy, for example: An RCT comparing valproic acid and lacosamide found that the agents were equally efficacious when adequately dosed (e.g., 400 mg IV lacosamide)

Poor Nutrition: Diets high in processed foods may lack the sulfur-rich amino acids needed for production